Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer.
Halamka, Magdalena
Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer. [electronic resource] - Oral oncology Aug 2011 - 763-7 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1879-0593
10.1016/j.oraloncology.2011.05.009 doi
Adult
Aged
Carcinoma, Squamous Cell--drug therapy
Celecoxib
Clinical Trials, Phase II as Topic
Combined Modality Therapy--adverse effects
Cyclooxygenase 2--metabolism
Cyclooxygenase 2 Inhibitors--administration & dosage
Female
Head and Neck Neoplasms--drug therapy
Humans
Male
Middle Aged
Pyrazoles--administration & dosage
Sulfonamides--administration & dosage
Vascular Endothelial Growth Factor A--blood
Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer. [electronic resource] - Oral oncology Aug 2011 - 763-7 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1879-0593
10.1016/j.oraloncology.2011.05.009 doi
Adult
Aged
Carcinoma, Squamous Cell--drug therapy
Celecoxib
Clinical Trials, Phase II as Topic
Combined Modality Therapy--adverse effects
Cyclooxygenase 2--metabolism
Cyclooxygenase 2 Inhibitors--administration & dosage
Female
Head and Neck Neoplasms--drug therapy
Humans
Male
Middle Aged
Pyrazoles--administration & dosage
Sulfonamides--administration & dosage
Vascular Endothelial Growth Factor A--blood